---
layout: default
title: Activated Charcoal Aesculus Hippocastanum Bark Ant
parent: 僅模型預測 (L5)
nav_order: 155
evidence_level: L5
indication_count: 0
---

# Activated Charcoal Aesculus Hippocastanum Bark Ant
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Botanical Formula: TxGNN Prediction Not Available

## One-Sentence Summary

This Evidence Pack describes a complex 25-ingredient botanical/homeopathic formula that is not currently marketed in the United States and has no DrugBank ID assigned to the multi-ingredient combination.
The TxGNN model was **unable to generate any repurposing prediction** for this formula — most likely because the combination product cannot be mapped to a single node in the DrugBank knowledge graph.
Without a valid prediction and without any registered indication, this candidate cannot proceed to formal repurposing evaluation at this time.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not established — no US licenses found |
| Predicted New Indication | No prediction available |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only) — in practice, no prediction was generated |
| US Market Status | Not marketed (0 NDAs) |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

The queried drug string consists of **25 distinct botanical and chemical ingredients**, including:

- Classical hepatic/lymphatic herbs: Cynara scolymus (artichoke), Taraxacum palustre (dandelion), Arctium lappa (burdock), Berberis vulgaris (barberry)
- Venous/circulatory botanicals: Aesculus hippocastanum (horse chestnut), Hamamelis virginiana (witch hazel), Vitis vinifera (grape)
- Mineral/chemical components: Activated charcoal, Antimony trisulfide, Silver nitrate, Cholesterol
- Traditional herbal tonics: Ginkgo, Goldenseal (Hydrastis canadensis), Cinchona bark, Fucus vesiculosus (bladderwrack), Arnica montana

The TxGNN knowledge graph operates at the level of **individual drug entities** mapped to DrugBank IDs. Because:

1. No DrugBank ID exists for this multi-ingredient combination (`drugbank_id: null`)
2. Each constituent ingredient would require a separate DrugBank entry to be scored independently
3. The query returned zero prediction results (`predicted_indications: []`)

…the model was structurally unable to evaluate this formula. This is a data architecture gap, not a negative prediction.

The combination profile is consistent with **homeopathic or naturopathic multi-botanical preparations** (e.g., lymphatic drainage formulas, hepatic support products). Such proprietary blends are typically not assigned unified regulatory identifiers in standard pharmacological databases.

---

## Safety Considerations

Please refer to the package insert for safety information.

> **Note on Silver Nitrate**: One ingredient — Silver Nitrate — is a corrosive inorganic salt with known caustic properties. Even in homeopathic dilutions, its presence warrants attention in any future full safety assessment.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline cannot evaluate a 25-component formula without individual DrugBank node mappings, and the product has no established indication or US market authorization to anchor a repurposing analysis.

**To proceed, the following is needed:**

- **Decompose the formula** — evaluate each of the 25 active ingredients individually through the TxGNN pipeline to identify which components may carry repurposing signal
- **Identify the lead ingredient(s)** — determine which constituent(s) are pharmacologically active and have a DrugBank ID (e.g., Berberine from *Berberis vulgaris*, Quinine from Cinchona bark, Ginkgolides from Ginkgo)
- **Clarify product identity** — confirm whether this is a licensed homeopathic product (OTC monograph), a dietary supplement, or an unlicensed compounded formula, as this determines the regulatory pathway
- **Retrieve original indication** — obtain any historical or intended-use labeling to establish the repurposing baseline
- **Obtain MOA data** — for key botanical actives with known pharmacology (e.g., Berberine: AMPK activation; Ginkgo: PAF inhibition; Horse chestnut: aescin / anti-edema)
- **Re-run TxGNN per-ingredient** — submit each mappable ingredient separately to generate individual prediction scores, then aggregate
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

